Psychopathological characteristics and social functioning of the schizophrenic patients with the T allele of the MTHFR677C>T polymorphism-Reference-Cited by-同舟云学术

Psychopathological characteristics and social functioning of the schizophrenic patients with the T allele of the MTHFR677C>T polymorphism

Published:2016 Issue:11 Volume:116 Page:5
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Zhilyaeva T. V.,Sergeeva A. V.,Blagonravova A. S.,Kasimova L. N.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference27 articles.

1. Aberrant folate status in schizophrenic patients: What is the evidence?

2. Zhiljaeva TV. Narushenija odnouglerodnogo metabolizma pri shizofrenii. Psihiatrija i psihofarmakoterapija. 2012;14(6):41-46. (In Russ.)

3. Zhiljaeva TV. Narushenija obmena folatov v svete dizontogeneticheskoj gipotezy jetiologii shizofrenii. Social'naja i klinicheskaja psihiatrija. 2012;22(1):88-94. (In Russ.)

4. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies

5. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the Relationship between Polymorphism of Human Leukocyte Antigen G (HLA-G) and Social Functioning of Patients with Schizophrenia;Russian Journal of Genetics;2022-03

2. The association of serum folate levels with schizophrenia symptoms;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022

3. Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium;Molecular Psychiatry;2019-01-21

4. Association study of methylenetetrahydrofolate reductase genetic polymorphism C677T with extrapyramidal side effects of antipsychotic treatment;European Neuropsychopharmacology;2019